scispace - formally typeset
B

Bernard Yan

Researcher at Royal Melbourne Hospital

Publications -  292
Citations -  15690

Bernard Yan is an academic researcher from Royal Melbourne Hospital. The author has contributed to research in topics: Stroke & Modified Rankin Scale. The author has an hindex of 37, co-authored 260 publications receiving 12338 citations. Previous affiliations of Bernard Yan include Columbia University & Goethe University Frankfurt.

Papers
More filters
Journal ArticleDOI

Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection

TL;DR: In patients with ischemic stroke with a proximal cerebral arterial occlusion and salvageable tissue on CT perfusion imaging, early thrombectomy with the Solitaire FR stent retriever, as compared with alteplase alone, improved reperfusion, early neurologic recovery, and functional outcome.
Journal ArticleDOI

Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial

Jörg Ederle, +351 more
- 20 Mar 2010 - 
TL;DR: Completion of long-term follow-up is needed to establish the efficacy of carotid artery stenting compared with endarterectomy, but in the meantime, carotin artery stent should remain the treatment of choice for patients suitable for surgery.
Journal ArticleDOI

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

TL;DR: Tenecteplase before thrombectomy was associated with a higher incidence of reperfusion and better functional outcome than alteplase among patients with ischemic stroke treated within 4.5 hours after symptom onset.
Journal ArticleDOI

Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.

Xinfeng Liu, +87 more
- 01 Feb 2020 - 
TL;DR: There was no evidence of a difference in favourable outcomes of patients receiving endovascular therapy compared with those receiving standard medical therapy alone, and the trial was terminated early after 131 patients had been randomly assigned because of high crossover rate and poor recruitment.